Cargando…
The efficacy and influence factors analysis of Mifepristone combined with estrogen-progesterone in the treatment of incomplete abortion
To analyze the efficacy and influencing factors of Mifepristone combined with estrogen-progesterone sequential therapy (Femoston) in the treatment of incomplete abortion. This retrospective cohort study included 93 patients with incomplete abortion. All patients took 50 mg of Mifepristone 2 times a...
Autores principales: | Wang, Kai, Zhuang, Ling-Ling, Shen, Hai-Lan, Su, Rui-De, Luo, Zhen-Yu, Wang, Wen-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082238/ https://www.ncbi.nlm.nih.gov/pubmed/37026901 http://dx.doi.org/10.1097/MD.0000000000033532 |
Ejemplares similares
-
The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017) -
Estrogen Supplementation to Progesterone as Luteal Phase Support in Patients Undergoing In Vitro Fertilization: Systematic Review and Meta-Analysis
por: Zhang, Xiao-Mei, et al.
Publicado: (2015) -
Evaluation of different doses of Femoston therapy for incomplete abortion: A prospective observational trial
por: Wang, Wenrong, et al.
Publicado: (2023) -
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017) -
Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report
por: Zhou, Guangdi, et al.
Publicado: (2022)